Literature DB >> 17400735

Membrane-bound nitrate reductase is required for anaerobic growth in cystic fibrosis sputum.

Kelli L Palmer1, Stacie A Brown, Marvin Whiteley.   

Abstract

The autosomal recessive disorder cystic fibrosis (CF) affects approximately 70,000 people worldwide and is characterized by chronic bacterial lung infections with the opportunistic pathogen Pseudomonas aeruginosa. To form a chronic CF lung infection, P. aeruginosa must grow and proliferate within the CF lung, and the highly viscous sputum within the CF lung provides a likely growth substrate. Recent evidence indicates that anaerobic microenvironments may be present in the CF lung sputum layer. Since anaerobic growth significantly enhances P. aeruginosa biofilm formation and antibiotic resistance, it is important to examine P. aeruginosa physiology and metabolism in anaerobic environments. Measurement of nitrate levels revealed that CF sputum contains sufficient nitrate to support significant P. aeruginosa growth anaerobically, and mutational analysis revealed that the membrane-bound nitrate reductase is essential for P. aeruginosa anaerobic growth in an in vitro CF sputum medium. In addition, expression of genes coding for the membrane-bound nitrate reductase complex is responsive to CF sputum nitrate levels. These findings suggest that the membrane-bound nitrate reductase is critical for P. aeruginosa anaerobic growth with nitrate in the CF lung.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17400735      PMCID: PMC1913347          DOI: 10.1128/JB.00162-07

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  40 in total

1.  Cascade regulation of the two CRP/FNR-related transcriptional regulators (ANR and DNR) and the denitrification enzymes in Pseudomonas aeruginosa.

Authors:  H Arai; T Kodama; Y Igarashi
Journal:  Mol Microbiol       Date:  1997-09       Impact factor: 3.501

2.  Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis.

Authors:  Sang Sun Yoon; Robert F Hennigan; George M Hilliard; Urs A Ochsner; Kislay Parvatiyar; Moneesha C Kamani; Holly L Allen; Teresa R DeKievit; Paul R Gardner; Ute Schwab; John J Rowe; Barbara H Iglewski; Timothy R McDermott; Ronald P Mason; Daniel J Wozniak; Robert E W Hancock; Matthew R Parsek; Terry L Noah; Richard C Boucher; Daniel J Hassett
Journal:  Dev Cell       Date:  2002-10       Impact factor: 12.270

3.  Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients.

Authors:  Dieter Worlitzsch; Robert Tarran; Martina Ulrich; Ute Schwab; Aynur Cekici; Keith C Meyer; Peter Birrer; Gabriel Bellon; Jürgen Berger; Tilo Weiss; Konrad Botzenhart; James R Yankaskas; Scott Randell; Richard C Boucher; Gerd Döring
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

4.  Anaerobic activation of the entire denitrification pathway in Pseudomonas aeruginosa requires Anr, an analog of Fnr.

Authors:  R W Ye; D Haas; J O Ka; V Krishnapillai; A Zimmermann; C Baird; J M Tiedje
Journal:  J Bacteriol       Date:  1995-06       Impact factor: 3.490

5.  Regulation of nap gene expression and periplasmic nitrate reductase activity in the phototrophic bacterium Rhodobacter sphaeroides DSM158.

Authors:  Mónica Gavira; M Dolores Roldán; Francisco Castillo; Conrado Moreno-Vivián
Journal:  J Bacteriol       Date:  2002-03       Impact factor: 3.490

Review 6.  Pathophysiology and management of pulmonary infections in cystic fibrosis.

Authors:  Ronald L Gibson; Jane L Burns; Bonnie W Ramsey
Journal:  Am J Respir Crit Care Med       Date:  2003-10-15       Impact factor: 21.405

7.  Anaerobic growth and cyanide synthesis of Pseudomonas aeruginosa depend on anr, a regulatory gene homologous with fnr of Escherichia coli.

Authors:  A Zimmermann; C Reimmann; M Galimand; D Haas
Journal:  Mol Microbiol       Date:  1991-06       Impact factor: 3.501

8.  Definition of nitrite and nitrate response elements at the anaerobically inducible Escherichia coli nirB promoter: interactions between FNR and NarL.

Authors:  K L Tyson; A I Bell; J A Cole; S J Busby
Journal:  Mol Microbiol       Date:  1993-01       Impact factor: 3.501

9.  Alterations in the formation of lipopolysaccharide and membrane vesicles on the surface of Pseudomonas aeruginosa PAO1 under oxygen stress conditions.

Authors:  W Sabra; H Lünsdorf; A-P Zeng
Journal:  Microbiology       Date:  2003-10       Impact factor: 2.777

Review 10.  Lung infections associated with cystic fibrosis.

Authors:  Jeffrey B Lyczak; Carolyn L Cannon; Gerald B Pier
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

View more
  66 in total

1.  Transcriptional patterns in both host and bacterium underlie a daily rhythm of anatomical and metabolic change in a beneficial symbiosis.

Authors:  Andrew M Wier; Spencer V Nyholm; Mark J Mandel; R Prisca Massengo-Tiassé; Amy L Schaefer; Irina Koroleva; Sandra Splinter-Bondurant; Bartley Brown; Liliana Manzella; Einat Snir; Hakeem Almabrazi; Todd E Scheetz; Maria de Fatima Bonaldo; Thomas L Casavant; M Bento Soares; John E Cronan; Jennifer L Reed; Edward G Ruby; Margaret J McFall-Ngai
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-19       Impact factor: 11.205

Review 2.  Are pathogenic bacteria just looking for food? Metabolism and microbial pathogenesis.

Authors:  Laurence Rohmer; Didier Hocquet; Samuel I Miller
Journal:  Trends Microbiol       Date:  2011-05-18       Impact factor: 17.079

Review 3.  The Yin and Yang of Streptococcus Lung Infections in Cystic Fibrosis: a Model for Studying Polymicrobial Interactions.

Authors:  Jessie E Scott; George A O'Toole
Journal:  J Bacteriol       Date:  2019-05-08       Impact factor: 3.490

4.  Vitamin B12-mediated restoration of defective anaerobic growth leads to reduced biofilm formation in Pseudomonas aeruginosa.

Authors:  Kang-Mu Lee; Junhyeok Go; Mi Young Yoon; Yongjin Park; Sang Cheol Kim; Dong Eun Yong; Sang Sun Yoon
Journal:  Infect Immun       Date:  2012-02-27       Impact factor: 3.441

5.  Susceptibility of Pseudomonas aeruginosa urinary tract isolates and influence of urinary tract conditions on antibiotic tolerance.

Authors:  Maike Narten; Nathalie Rosin; Max Schobert; Petra Tielen
Journal:  Curr Microbiol       Date:  2011-10-08       Impact factor: 2.188

6.  Nitric oxide production by polymorphonuclear leucocytes in infected cystic fibrosis sputum consumes oxygen.

Authors:  M Kolpen; T Bjarnsholt; C Moser; C R Hansen; L F Rickelt; M Kühl; C Hempel; T Pressler; N Høiby; P Ø Jensen
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

7.  Metabolic compensation of fitness costs associated with overexpression of the multidrug efflux pump MexEF-OprN in Pseudomonas aeruginosa.

Authors:  Jorge Olivares; Carolina Álvarez-Ortega; José Luis Martinez
Journal:  Antimicrob Agents Chemother       Date:  2014-04-28       Impact factor: 5.191

8.  The Pseudomonas aeruginosa CreBC two-component system plays a major role in the response to β-lactams, fitness, biofilm growth, and global regulation.

Authors:  Laura Zamorano; Bartolomé Moyà; Carlos Juan; Xavier Mulet; Jesús Blázquez; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2014-06-16       Impact factor: 5.191

9.  Proteomic, microarray, and signature-tagged mutagenesis analyses of anaerobic Pseudomonas aeruginosa at pH 6.5, likely representing chronic, late-stage cystic fibrosis airway conditions.

Authors:  Mark D Platt; Michael J Schurr; Karin Sauer; Gustavo Vazquez; Irena Kukavica-Ibrulj; Eric Potvin; Roger C Levesque; Amber Fedynak; Fiona S L Brinkman; Jill Schurr; Sung-Hei Hwang; Gee W Lau; Patrick A Limbach; John J Rowe; Michael A Lieberman; Nicolas Barraud; Jeremy Webb; Staffan Kjelleberg; Donald F Hunt; Daniel J Hassett
Journal:  J Bacteriol       Date:  2008-01-18       Impact factor: 3.490

10.  Nutrient availability as a mechanism for selection of antibiotic tolerant Pseudomonas aeruginosa within the CF airway.

Authors:  Lucas R Hoffman; Anthony R Richardson; Laura S Houston; Hemantha D Kulasekara; Willm Martens-Habbena; Mikkel Klausen; Jane L Burns; David A Stahl; Daniel J Hassett; Ferric C Fang; Samuel I Miller
Journal:  PLoS Pathog       Date:  2010-01-08       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.